Search

Royal Emerald Pharma DEA Controlled Substances Application

The Drug Enforcement Administration published notice that Royal Emerald Pharmaceuticals, 14011 Palm Drive, Building B, Desert Hot Springs, California 92240-6845, applied on March 3, 2026 to be registered as an importer of three Schedule I controlled substance basic classes: Marihuana Extract (7350), Marihuana (7360), and Tetrahydrocannabinols (7370). The company plans to import immature plants for continued cultivation under its Bulk Manufacturing registration. Registered bulk manufacturers and applicants may submit electronic comments or written hearing requests on or before May 18, 2026.

Royal Emerald Pharmaceuticals Controlled Substances Importer Registration

The Drug Enforcement Administration published a notice of application by Royal Emerald Pharmaceuticals for registration as an importer of controlled substances. The notice invites public comment on the application for 31 days from the publication date. Under 21 U.S.C. 957, applicants must demonstrate compliance with registration requirements before obtaining authority to import controlled substances.